XM
Xavier Mesnier
Principal France & UK at Verve Ventures
Lausanne, Vaud
Overview
Xavier Mesnier is currently serving as the TechBio & Deeptech VC at Verve Ventures, focusing on private investments and venture capital in sectors like DeepTech and Digital Health. With a background in R&D and project management, Xavier has successfully invested in companies like Orakl Oncology and has held key roles at Nitto Denko Technical Corporation and NATUREX, showcasing a strong track record in the food technology and health industries.
Work Experience
Principal France & UK
2022 - Current
Responsible for the French (Paris) and UK (Cambridge) offices of Verve Ventures Investments include: - Orakl Oncology (Fr) - Poppins.io (Fr) - Multiomic.health (UK) - Figures (Fr) - Helios (Fr) - Therapixel (Fr) - C12 (Fr) - Veesion (Fr) - Groover (Fr) - WeMaintain (Fr) - Otoqi (Fr) - FineHeart (Fr) - Andjaro (Fr) - Cambrian Biopharma (USA) - Medtrace (DK) - ecoRobotix (CH) - Insolight (CH)
Investment Manager - France
2020 - 2022
Associate
2018 - 2019
Intrapreneur in Health & Bio
2015 - 2017
Scientific Coordinator
2013 - 2015
PhD Chemical & Biological Engineering
2009 - 2013
Master thesis
2008 - 2009
Carried out at the Nestle Research Centre in Switzerland
Process Engineer
2008 - 2008
Education
Ingénieur - Meng
2005 - 2009
Finance Fundamentals Executive Course
2017 - 2017
Being Innovative Executive Course
2017 - 2017
Doctor of Philosophy (PhD)
2009 - 2013
Master of Science (MSc)
2007 - 2009